API Innovation Center Launches the U.S.’ First Benchmark for Pharmaceutical Supply Chain FragilityMore than 550 million prescriptions were filled for medicines with High or Severe supply-chain fragility, according to APIIC’s new national benchmark
API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White PaperReport outlines how measuring supply chain fragility can guide policy, investment and procurement reform
The API Innovation Center Receives $14 Million in Strategic Funding to Bolster U.S. Pharmaceutical Independence
The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC) to lead the development and domestic production of three critical active pharmaceutical ingredients (APIs) used in the treatment of asthma, diabetes, and anxiety disorders. APIIC will leverage advanced manufacturing technologies and cutting-edge research to further national strength in pharmaceutical innovation and supply chain resilience.
